Louis Gleckel M.D., Director at ProPhase Labs, Inc. (PRPH), bought 50,000 shares at $2.75 ($138K) on 2020-08-13, disclosed to the SEC on 2020-08-17.
Open-market purchase of $138k PRPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.